Results: 34
#1
au:Ramos, Marcelo Alves
Filters
Order by
Page
of 3
Next
1.
Aplicação do saber científico: a translação do conhecimento em um instituto de ciência e tecnologia em saúde pública
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Scavuzzi, Ângela Maria Andrade
; Reis, Valdeyer Galvão dos
; Ramos, Marcelo Santos
; Souza, Maria Julia Alves de
; Winkler, Ingrid
; Pereira-Guizzo, Camila de Sousa
.
Resumen: La traslación del conocimiento (TC) tiene como propósito el uso práctico de los resultados de investigaciones científicas y el seguimiento de los beneficios causados a la salud de la población. En el área de la salud, el gobierno y, sobre todo, la sociedad esperan que las inversiones en investigaciones obtengan resultados que vayan más allá de la producción y publicación de conocimiento, y provoquen resultados, como políticas públicas, sistemas, productos y tecnologías en beneficio de la salud de la población. Sin embargo, se observa aun la necesidad de superar diversos desafíos para eliminar las brechas entre la investigación y la aplicación. El objetivo de este estudio es proponer estrategias con base en la identificación de barreras y factores facilitadores de un instituto de ciencia y tecnología (ICT) en salud, para fomentar el proceso de transformación del conocimiento científico generado en las investigaciones en acciones y productos que contribuyan a mejorar la salud de la población. Los relatos de las entrevistas a 16 investigadores permitieron identificar 10 categorías de barreras, con énfasis en: “financiación en CT&I limitado” y “apoyo técnico insuficiente para la traslación del conocimiento”. “Infraestructura y apoyo institucional” fue la categoría de factores facilitadores más citada por los participantes. Finalmente, se desarrolló el artefacto “estrategias y enfoques para la superación de barreras a la implementación de resultados de investigación”. Entre las estrategias, se sugiere la inclusión de una asignatura de TC en los programas de posgrado stricto sensu y la creación de una instancia en la estructura organizacional del ICT orientada a brindar apoyo técnico y gerencial a la aplicación de los resultados de la investigación.
Resumo: A translação do conhecimento (TC) tem como propósito a utilização prática dos resultados de pesquisas científicas e o monitoramento dos benefícios causados à saúde da população. Na área de saúde, o governo e, principalmente, a sociedade esperam que os investimentos em pesquisas obtenham resultados que vão além da produção e da publicação do conhecimento, e provoquem soluções como políticas públicas, sistemas, produtos e tecnologias para beneficiar a saúde da população. Contudo, verifica-se ainda a necessidade de superar diversos desafios para eliminar as lacunas existentes entre a investigação e a aplicação. O objetivo deste estudo é propor estratégias, com base na identificação de barreiras e fatores facilitadores de um instituto de ciência e tecnologia (ICT) em saúde, para fomentar o processo de transformação do conhecimento científico, gerado nas pesquisas, em ações e produtos que contribuam para a melhoria da saúde da população. Os relatos das entrevistas, realizadas com 16 pesquisadores, permitiram a identificação de 10 categorias de barreiras, tendo destaque: “financiamento em ciência, tecnologia e informação (CT&I) limitado” e “apoio técnico insuficiente para a translação do conhecimento”. “Infraestrutura e apoio institucional” foi a categoria de fatores facilitadores mais citada pelos participantes. Por fim, foi desenvolvido o artefato “estratégias e abordagens para superação de barreiras à implementação de resultados de pesquisa”. Entre as estratégias, sugere-se a inclusão de uma disciplina de TC nos programas de pós-graduação stricto sensu e a criação de uma instância na estrutura organizacional do ICT voltada à prestação de suporte técnico e gerencial à aplicação de resultados de pesquisa.
Abstract: Knowledge translation (KT) aims at the practical use of scientific research results and at the monitoring of the benefits caused to the population’s health. In health, the government and especially society expect that investments in research will produce results that go beyond the production and publication of knowledge, provoking outcomes such as public policies, systems, products, and technologies to benefit the health of the population. However, closing the gaps between research and application requires overcoming a number of challenges. This study aimed to propose strategies to foster the process of transforming the scientific knowledge generated in research into actions and products that contribute to improving the population’s health based on the identification of barriers and facilitating factors of a health science and technology institute. The reports of interviews conducted with 16 researchers showed 10 categories of barriers, especially: “limited funding to the science and technology institute” and “insufficient technical support for knowledge translation”. “Infrastructure and institutional support” was the facilitating factor category participants mentioned the most. Finally, we developed the artifact “strategies and approaches for overcoming barriers to implement research results”. Among the strategies, we suggest the inclusion of a knowledge translation discipline in stricto sensu graduate programs and the creation of an instance in the organizational structure of the science and technology institute to technically and managerially support the application of research results.
2.
Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com Cardiomiopatia da Doença de Chagas – 2023
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Marin-Neto, José Antonio
; Rassi Jr, Anis
; Oliveira, Gláucia Maria Moraes
; Correia, Luís Claudio Lemos
; Ramos Júnior, Alberto Novaes
; Luquetti, Alejandro Ostermayer
; Hasslocher-Moreno, Alejandro Marcel
; Sousa, Andréa Silvestre de
; Paola, Angelo Amato Vincenzo de
; Sousa, Antônio Carlos Sobral
; Ribeiro, Antonio Luiz Pinho
; Correia Filho, Dalmo
; Souza, Dilma do Socorro Moraes de
; Cunha-Neto, Edecio
; Ramires, Felix Jose Alvarez
; Bacal, Fernando
; Nunes, Maria do Carmo Pereira
; Martinelli Filho, Martino
; Scanavacca, Maurício Ibrahim
; Saraiva, Roberto Magalhães
; Oliveira Júnior, Wilson Alves de
; Lorga-Filho, Adalberto Menezes
; Guimarães, Adriana de Jesus Benevides de Almeida
; Braga, Adriana Lopes Latado
; Oliveira, Adriana Sarmento de
; Sarabanda, Alvaro Valentim Lima
; Pinto, Ana Yecê das Neves
; Carmo, Andre Assis Lopes do
; Schmidt, Andre
; Costa, Andréa Rodrigues da
; Ianni, Barbara Maria
; Markman Filho, Brivaldo
; Rochitte, Carlos Eduardo
; Macêdo, Carolina Thé
; Mady, Charles
; Chevillard, Christophe
; Virgens, Cláudio Marcelo Bittencourt das
; Castro, Cleudson Nery de
; Britto, Constança Felicia De Paoli de Carvalho
; Pisani, Cristiano
; Rassi, Daniela do Carmo
; Sobral Filho, Dário Celestino
; Almeida, Dirceu Rodrigues de
; Bocchi, Edimar Alcides
; Mesquita, Evandro Tinoco
; Mendes, Fernanda de Souza Nogueira Sardinha
; Gondim, Francisca Tatiana Pereira
; Silva, Gilberto Marcelo Sperandio da
; Peixoto, Giselle de Lima
; Lima, Gustavo Glotz de
; Veloso, Henrique Horta
; Moreira, Henrique Turin
; Lopes, Hugo Bellotti
; Pinto, Ibraim Masciarelli Francisco
; Ferreira, João Marcos Bemfica Barbosa
; Nunes, João Paulo Silva
; Barreto-Filho, José Augusto Soares
; Saraiva, José Francisco Kerr
; Lannes-Vieira, Joseli
; Oliveira, Joselina Luzia Menezes
; Armaganijan, Luciana Vidal
; Martins, Luiz Cláudio
; Sangenis, Luiz Henrique Conde
; Barbosa, Marco Paulo Tomaz
; Almeida-Santos, Marcos Antonio
; Simões, Marcos Vinicius
; Yasuda, Maria Aparecida Shikanai
; Moreira, Maria da Consolação Vieira
; Higuchi, Maria de Lourdes
; Monteiro, Maria Rita de Cassia Costa
; Mediano, Mauro Felippe Felix
; Lima, Mayara Maia
; Oliveira, Maykon Tavares de
; Romano, Minna Moreira Dias
; Araujo, Nadjar Nitz Silva Lociks de
; Medeiros, Paulo de Tarso Jorge
; Alves, Renato Vieira
; Teixeira, Ricardo Alkmim
; Pedrosa, Roberto Coury
; Aras Junior, Roque
; Torres, Rosalia Morais
; Povoa, Rui Manoel dos Santos
; Rassi, Sergio Gabriel
; Alves, Silvia Marinho Martins
; Tavares, Suelene Brito do Nascimento
; Palmeira, Swamy Lima
; Silva Júnior, Telêmaco Luiz da
; Rodrigues, Thiago da Rocha
; Madrini Junior, Vagner
; Brant, Veruska Maia da Costa
; Dutra, Walderez Ornelas
; Dias, João Carlos Pinto
.
3.
Development of inclusion complex based on cyclodextrin and oxazolidine derivative
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Silva, Rafael Ramos
; Amorim, Cézar Augusto da Cruz
; Lima, Maria do Carmo Alves
; Rabello, Marcelo Montenegro
; Hernandes, Marcelo Zaldini
; Rêgo, Moacyr Jesus Barreto de Melo
; Pitta, Maira Galdino da Rocha
; Oliveira, Maria Danielly Lima de
; Andrade, César Augusto Souza de
.
Abstract Oxazolidine derivatives (OxD) have been described as third-line antibiotics and antitumoral agents. The inclusion complexes based on cyclodextrin could improve the solubility and bioavailability of these compounds. A novel synthetic OxD was used, and its inclusion complexes were based on 2-hydroxy-beta-cyclodextrin (2-HPβCD). We conducted an in silico study to evaluate the interaction capacity between OxD and 2-HPβCD. Characterization studies were performed through scanning electron microscopy (SEM), Fourier-transformed infrared (FTIR), nuclear magnetic resonance spectroscopy (1H-NMR), X-ray diffraction (XRD), and thermal analyses. A kinetic study of the OxD was performed, including a cytotoxicity assay using peripheral blood mononuclear cells (PBMCs). The maximum increment of solubility was obtained at 70 mM OxD using 400 mM 2-HPβCD. SEM analyses and FTIR spectra indicated the formation of inclusion complexes. 1H-NMR presented chemical shifts that indicated 1:1 stoichiometry. Different thermal behaviors were obtained. The pharmacokinetic profile showed a short release time. Pure OxD and its inclusion complex did not exhibit cytotoxicity in PBMCs. In silico studies provided a foremost insight into the interactions between OxD and 2-HPβCD, including a higher solubility in water and an average releasing profile without toxicity in normal cells.
4.
Chikungunya virus infection in the southernmost state of Brazil was characterised by self-limited transmission (2017-2019) and a larger 2021 outbreak
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Gregianini, Tatiana Schäffer
; Salvato, Richard Steiner
; Barcellos, Regina Bones
; Godinho, Fernanda Marques
; Ruivo, Amanda Pellenz
; de Melo, Viviane Horn
; Schroder, Júlio Augusto
; Martiny, Fernanda Letícia
; Möllmann, Erica Bortoli
; Favreto, Cátia
; Baethgen, Ludmila Fiorenzano
; Ferreira, Vithoria Pompermaier
; de Lima, Lívia Eidt
; Piazza, Cláudia Fasolo
; Machado, Taís Raquel Marcon
; Becker, Irina Marieta
; Ramos, Raquel Rocha
; Frölich, Guilherme Carey
; Rossetti, Alana Fraga
; Almeida, Lucas da Cunha
; Rodrigues, Tahiana Machado Antunes
; Bragança, Isabella Tabelli
; Campos, Aline Alves Scarpellini
; Manzoni, Verônica Baú
; Machado, Lais Ceschini
; da Silva, Luisa Maria Inácio
; de Oliveira, André Luiz Sá
; Paiva, Marcelo Henrique Santos
; Nunes, Zenaida Marion Alves
; de Almeida, Paula Rodrigues
; Demoliner, Meriane
; Gularte, Juliana Schons
; da Silva, Mariana Soares
; Filippi, Micheli
; Pereira, Vyctoria Malayhka de Abreu Góes
; Spilki, Fernando Rosado
; da Veiga, Ana Beatriz Gorini
; Wallau, Gabriel Luz
.
BACKGROUND Chikungunya is a mosquito-borne virus that has been causing large outbreaks in the Americas since 2014. In Brazil, Asian-Caribbean (AC) and East-Central-South-African (ECSA) genotypes have been detected and lead to large outbreaks in several Brazilian states. In Rio Grande do Sul (RS), the southernmost state of Brazil, the first cases were reported in 2016. OBJECTIVES AND METHODS We employed genome sequencing and epidemiological investigation to characterise the Chikungunya fever (CHIKF) burden in RS between 2017-2021. FINDINGS We detected an increasing CHIKF burden linked to travel associated introductions and communitary transmission of distinct lineages of the ECSA genotype during this period. MAIN CONCLUSIONS Until 2020, CHIKV introductions were most travel associated and transmission was limited. Then, in 2021, the largest outbreak occurred in the state associated with the introduction of a new ECSA lineage. CHIKV outbreaks are likely to occur in the near future due to abundant competent vectors and a susceptible population, exposing more than 11 million inhabitants to an increasing infection risk.
5.
COVID-19 outcomes in people living with HIV: Peering through the waves
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Sales, Thaís Lorenna Souza
; Souza-Silva, Maíra Viana Rego
; Delfino-Pereira, Polianna
; Neves, João Victor Baroni
; Sacioto, Manuela Furtado
; Assis, Vivian Costa Morais de
; Duani, Helena
; Oliveira, Neimy Ramos de
; Sampaio, Natália da Cunha Severino
; Ramos, Lucas Emanuel Ferreira
; Schwarzbold, Alexandre Vargas
; Jorge, Alzira de Oliveira
; Scotton, Ana Luiza Bahia Alves
; Castro, Bruno Mateus de
; Silva, Carla Thais Cândida Alves da
; Ramos, Carolina Marques
; Anschau, Fernando
; Botoni, Fernando Antonio
; Grizende, Genna Maira Santos
; Nascimento, Guilherme Fagundes
; Ruschel, Karen Brasil
; Menezes, Luanna Silva Monteiro
; Castro, Luís César de
; Nasi, Luiz Antônio
; Carneiro, Marcelo
; Godoy, Mariana Frizzo de
; Nogueira, Matheus Carvalho Alves
; Guimarães Júnior, Milton Henriques
; Ziegelmann, Patricia Klarmann
; Almeida, Rafaela Charão de
; Francisco, Saionara Cristina
; Silveira Neto, Sidney Teodoro
; Araújo, Silvia Ferreira
; Avelino-Silva, Thiago Junqueira
; Aliberti, Márlon Juliano Romero
; Pires, Magda Carvalho
; Silva, Eduardo Sérgio da
; Marcolino, Milena Soriano
.
Abstract Objective To evaluate clinical characteristics and outcomes of COVID-19 patients infected with HIV, and to compare with a paired sample without HIV infection. Methods This is a substudy of a Brazilian multicentric cohort that comprised two periods (2020 and 2021). Data was obtained through the retrospective review of medical records. Primary outcomes were admission to the intensive care unit, invasive mechanical ventilation, and death. Patients with HIV and controls were matched for age, sex, number of comorbidities, and hospital of origin using the technique of propensity score matching (up to 4:1). They were compared using the Chi-Square or Fisher's Exact tests for categorical variables and the Wilcoxon for numerical variables. Results Throughout the study, 17,101 COVID-19 patients were hospitalized, and 130 (0.76%) of those were infected with HIV. The median age was 54 (IQR: 43.0;64.0) years in 2020 and 53 (IQR: 46.0;63.5) years in 2021, with a predominance of females in both periods. People Living with HIV (PLHIV) and their controls showed similar prevalence for admission to the ICU and invasive mechanical ventilation requirement in the two periods, with no significant differences. In 2020, in-hospital mortality was higher in the PLHIV compared to the controls (27.9% vs. 17.7%; p = 0.049), but there was no difference in mortality between groups in 2021 (25.0% vs. 25.1%; p > 0.999). Conclusions Our results reiterate that PLHIV were at higher risk of COVID-19 mortality in the early stages of the pandemic, however, this finding did not sustain in 2021, when the mortality rate is similar to the control group.
6.
Aplicação do saber científico: a translação do conhecimento em um instituto de ciência e tecnologia em saúde pública
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Scavuzzi, Ângela Maria Andrade
; Reis, Valdeyer Galvão dos
; Ramos, Marcelo Santos
; Souza, Maria Julia Alves de
; Winkler, Ingrid
; Pereira-Guizzo, Camila de Sousa
.
Abstract: Knowledge translation (KT) aims at the practical use of scientific research results and at the monitoring of the benefits caused to the population’s health. In health, the government and especially society expect that investments in research will produce results that go beyond the production and publication of knowledge, provoking outcomes such as public policies, systems, products, and technologies to benefit the health of the population. However, closing the gaps between research and application requires overcoming a number of challenges. This study aimed to propose strategies to foster the process of transforming the scientific knowledge generated in research into actions and products that contribute to improving the population’s health based on the identification of barriers and facilitating factors of a health science and technology institute. The reports of interviews conducted with 16 researchers showed 10 categories of barriers, especially: “limited funding to the science and technology institute” and “insufficient technical support for knowledge translation”. “Infrastructure and institutional support” was the facilitating factor category participants mentioned the most. Finally, we developed the artifact “strategies and approaches for overcoming barriers to implement research results”. Among the strategies, we suggest the inclusion of a knowledge translation discipline in stricto sensu graduate programs and the creation of an instance in the organizational structure of the science and technology institute to technically and managerially support the application of research results.
Resumen: La traslación del conocimiento (TC) tiene como propósito el uso práctico de los resultados de investigaciones científicas y el seguimiento de los beneficios causados a la salud de la población. En el área de la salud, el gobierno y, sobre todo, la sociedad esperan que las inversiones en investigaciones obtengan resultados que vayan más allá de la producción y publicación de conocimiento, y provoquen resultados, como políticas públicas, sistemas, productos y tecnologías en beneficio de la salud de la población. Sin embargo, se observa aun la necesidad de superar diversos desafíos para eliminar las brechas entre la investigación y la aplicación. El objetivo de este estudio es proponer estrategias con base en la identificación de barreras y factores facilitadores de un instituto de ciencia y tecnología (ICT) en salud, para fomentar el proceso de transformación del conocimiento científico generado en las investigaciones en acciones y productos que contribuyan a mejorar la salud de la población. Los relatos de las entrevistas a 16 investigadores permitieron identificar 10 categorías de barreras, con énfasis en: “financiación en CT&I limitado” y “apoyo técnico insuficiente para la traslación del conocimiento”. “Infraestructura y apoyo institucional” fue la categoría de factores facilitadores más citada por los participantes. Finalmente, se desarrolló el artefacto “estrategias y enfoques para la superación de barreras a la implementación de resultados de investigación”. Entre las estrategias, se sugiere la inclusión de una asignatura de TC en los programas de posgrado stricto sensu y la creación de una instancia en la estructura organizacional del ICT orientada a brindar apoyo técnico y gerencial a la aplicación de los resultados de la investigación.
Resumo: A translação do conhecimento (TC) tem como propósito a utilização prática dos resultados de pesquisas científicas e o monitoramento dos benefícios causados à saúde da população. Na área de saúde, o governo e, principalmente, a sociedade esperam que os investimentos em pesquisas obtenham resultados que vão além da produção e da publicação do conhecimento, e provoquem soluções como políticas públicas, sistemas, produtos e tecnologias para beneficiar a saúde da população. Contudo, verifica-se ainda a necessidade de superar diversos desafios para eliminar as lacunas existentes entre a investigação e a aplicação. O objetivo deste estudo é propor estratégias, com base na identificação de barreiras e fatores facilitadores de um instituto de ciência e tecnologia (ICT) em saúde, para fomentar o processo de transformação do conhecimento científico, gerado nas pesquisas, em ações e produtos que contribuam para a melhoria da saúde da população. Os relatos das entrevistas, realizadas com 16 pesquisadores, permitiram a identificação de 10 categorias de barreiras, tendo destaque: “financiamento em ciência, tecnologia e informação (CT&I) limitado” e “apoio técnico insuficiente para a translação do conhecimento”. “Infraestrutura e apoio institucional” foi a categoria de fatores facilitadores mais citada pelos participantes. Por fim, foi desenvolvido o artefato “estratégias e abordagens para superação de barreiras à implementação de resultados de pesquisa”. Entre as estratégias, sugere-se a inclusão de uma disciplina de TC nos programas de pós-graduação stricto sensu e a criação de uma instância na estrutura organizacional do ICT voltada à prestação de suporte técnico e gerencial à aplicação de resultados de pesquisa.
7.
[SciELO Preprints] - Guideline of the Brazilian Society of Cardiology on Diagnosis and Treatment of Patients with Chagas Disease Cardiomyopathy
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Marin-Neto, José Antonio
Rassi Jr., Anis
Moraes Oliveira, Gláucia M.
Lemos Correia, Luís Claudio
Novaes Ramos Jr., Alberto
Hasslocher-Moreno, Alejandro Marcel
Luquetti Ostermayer, Alejandro
Sousa, Andréa Silvestre de
Amato Vincenzo de Paola, Angelo
Sobral de Sousa, Antonio Carlos
Pinho Ribeiro, Antonio Luiz
Correia Filho, Dalmo
Moraes de Souza, Dilma do Socorro
Cunha-Neto, Edecio
J. A. Ramires, Felix
Bacal, Fernando
Pereira Nunes, Maria do Carmo
Martinelli Filho, Martino
Ibrahim Scanavacca, Maurício
Magalhães Saraiva, Roberto
Alves de Oliveira Júnior, Wilson
M. Lorga-Filho, Adalberto
de Jesus Benevides de Almeida Guimarães, Adriana
Lopes Latado Braga, Adriana
Sarmento de Oliveira, Adriana
V. L. Sarabanda, Alvaro
Yecê das Neves Pinto, Ana
Assis Lopes do Carmo, André
Schmidt, André
Costa, Andréa Rodrigues da
Ianni, Barbara Maria
Markman Filho, Brivaldo
Eduardo Rochitte, Carlos
Thé Macedo, Carolina
Mady, Charles
Chevillard, Christophe
Bittencourt das Virgens, Cláudio Marcelo
Nery de Castro, Cleudson
De Paoli de Carvalho Britto, Constança Felícia
Pisani, Cristiano
do Carmo Rassi, Daniela
C. Sobral Filho, Dario
Rodrigues Almeida, Dirceu
A. Bocchi, Edimar
T. Mesquita, Evandro
de Souza Nogueira Sardinha Mendes, Fernanda
Pereira, Francisca Tatiana
Sperandio da Silva, Gilberto Marcelo
de Lima Peixoto, Giselle
Glotz de Lima, Gustavo
H. Veloso, Henrique
Turin Moreira, Henrique
Bellotti Lopes, Hugo
Masciarelli Francisco Pinto, Ibraim
Pinto Dias, João Carlos
Bemfica, João Marcos
Silva-Nunes, João Paulo
Soares Barreto-Filho, José Augusto
Kerr Saraiva, José Francisco
Lannes-Vieira, Joseli
Menezes Oliveira, Joselina Luzia
V. Armaganijan, Luciana
Martins, Luiz Cláudio
C. Sangenis, Luiz Henrique
Barbosa, Marco Paulo
Almeida-Santos, Marcos Antônio
Simões, Marcos Vinicius
Shikanai-Yasuda, Maria Aparecida
Vieira Moreira, Maria da Consolação
Higuchi, Maria de Lourdes
Costa Monteiro, Maria Rita de Cássia
Felix Mediano, Mauro Felippe
Maia Lima, Mayara
T. Oliveira, Maykon
Moreira Dias Romano , Minna
Nitz, Nadjar
de Tarso Jorge Medeiros, Paulo
Vieira Alves, Renato
Alkmim Teixeira, Ricardo
Coury Pedrosa, Roberto
Aras, Roque
Morais Torres, Rosália
dos Santos Povoa, Rui Manoel
Rassi, Sérgio Gabriel
Salles Xavier, Sérgio
Marinho Martins Alves , Silvia
B. N. Tavares, Suelene
Lima Palmeira, Swamy
da Silva Junior, Telêmaco Luiz
da Rocha Rodrigues, Thiago
Madrini Junior, Vagner
Maia da Costa , Veruska
Dutra, Walderez
This guideline aimed to update the concepts and formulate the standards of conduct and scientific evidence that support them, regarding the diagnosis and treatment of the Cardiomyopathy of Chagas disease, with special emphasis on the rationality base that supported it.nbsp;
Chagas disease in the 21st century maintains an epidemiological pattern of endemicity in 21 Latin American countries. Researchers and managers from endemic and non-endemic countries point to the need to adopt comprehensive public health policies to effectively control the interhuman transmission of T. cruzi infection, and to obtain an optimized level of care for already infected individuals, focusing on diagnostic and therapeutic opportunistic opportunities.
nbsp;
Pathogenic and pathophysiological mechanisms of the Cardiomyopathy of Chagas disease were revisited after in-depth updating and the notion that necrosis and fibrosis are stimulated by tissue parasitic persistence and adverse immune reaction, as fundamental mechanisms, assisted by autonomic and microvascular disorders, was well established. Some of them have recently formed potential targets of therapies.nbsp;
The natural history of the acute and chronic phases was reviewed, with enhancement for oral transmission, indeterminate form and chronic syndromes. Recent meta-analyses of observational studies have estimated the risk of evolution from acute and indeterminate forms and mortality after chronic cardiomyopathy. Therapeutic approaches applicable to individuals with Indeterminate form of Chagas disease were specifically addressed. All methods to detect structural and/or functional alterations with various cardiac imaging techniques were also reviewed, with recommendations for use in various clinical scenarios. Mortality risk stratification based on the Rassi score, with recent studies of its application, was complemented by methods that detect myocardial fibrosis.nbsp;
The current methodology for etiological diagnosis and the consequent implications of trypanonomic treatment deserved a comprehensive and in-depth approach. Also the treatment of patients at risk or with heart failure, arrhythmias and thromboembolic events, based on pharmacological and complementary resources, received special attention. Additional chapters supported the conducts applicable to several special contexts, including t. cruzi/HIV co-infection, risk during surgeries, in pregnant women, in the reactivation of infection after heart transplantation, and others.nbsp; nbsp;nbsp;
Finally, two chapters of great social significance, addressing the structuring of specialized services to care for individuals with the Cardiomyopathy of Chagas disease, and reviewing the concepts of severe heart disease and its medical-labor implications completed this guideline.
Esta diretriz teve como objetivo principal atualizar os conceitos e formular as normas de conduta e evidências científicas que as suportam, quanto ao diagnóstico e tratamento da CDC, com especial ênfase na base de racionalidade que a embasou.
A DC no século XXI mantém padrão epidemiológico de endemicidade em 21 países da América Latina. Investigadores e gestores de países endêmicos e não endêmicos indigitam a necessidade de se adotarem políticas abrangentes, de saúde pública, para controle eficaz da transmissão inter-humanos da infecção pelo T. cruzi, e obter-se nível otimizado de atendimento aos indivíduos já infectados, com foco em oportunização diagnóstica e terapêutica.
Mecanismos patogênicos e fisiopatológicos da CDC foram revisitados após atualização aprofundada e ficou bem consolidada a noção de que necrose e fibrose sejam estimuladas pela persistência parasitária tissular e reação imune adversa, como mecanismos fundamentais, coadjuvados por distúrbios autonômicos e microvasculares. Alguns deles recentemente constituíram alvos potenciais de terapêuticas.
A história natural das fases aguda e crônica foi revista, com realce para a transmissão oral, a forma indeterminada e as síndromes crônicas. Metanálises recentes de estudos observacionais estimaram o risco de evolução a partir das formas aguda e indeterminada e de mortalidade após instalação da cardiomiopatia crônica. Condutas terapêuticas aplicáveis aos indivíduos com a FIDC foram abordadas especificamente. Todos os métodos para detectar alterações estruturais e/ou funcionais com variadas técnicas de imageamento cardíaco também foram revisados, com recomendações de uso nos vários cenários clínicos. Estratificação de risco de mortalidade fundamentada no escore de Rassi, com estudos recentes de sua aplicação, foi complementada por métodos que detectam fibrose miocárdica.
A metodologia atual para diagnóstico etiológico e as consequentes implicações do tratamento tripanossomicida mereceram enfoque abrangente e aprofundado. Também o tratamento de pacientes em risco ou com insuficiência cardíaca, arritmias e eventos tromboembólicos, baseado em recursos farmacológicos e complementares, recebeu especial atenção. Capítulos suplementares subsidiaram as condutas aplicáveis a diversos contextos especiais, entre eles o da co-infecção por T. cruzi/HIV, risco durante cirurgias, em grávidas, na reativação da infecção após transplante cardíacos, e outros.nbsp;nbsp;nbsp;
Por fim, dois capítulos de grande significado social, abordando a estruturação de serviços especializados para atendimento aos indivíduos com a CDC, e revisando os conceitos de cardiopatia grave e suas implicações médico-trabalhistas completaram esta diretriz.nbsp;
8.
Diretrizes da Sociedade Brasileira de Cardiologia sobre Angina Instável e Infarto Agudo do Miocárdio sem Supradesnível do Segmento ST – 2021
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Nicolau, José Carlos
; Feitosa Filho, Gilson Soares
; Petriz, João Luiz
; Furtado, Remo Holanda de Mendonça
; Précoma, Dalton Bertolim
; Lemke, Walmor
; Lopes, Renato Delascio
; Timerman, Ari
; Marin Neto, José A.
; Bezerra Neto, Luiz
; Gomes, Bruno Ferraz de Oliveira
; Santos, Eduardo Cavalcanti Lapa
; Piegas, Leopoldo Soares
; Soeiro, Alexandre de Matos
; Negri, Alexandre Jorge de Andrade
; Franci, Andre
; Markman Filho, Brivaldo
; Baccaro, Bruno Mendonça
; Montenegro, Carlos Eduardo Lucena
; Rochitte, Carlos Eduardo
; Barbosa, Carlos José Dornas Gonçalves
; Virgens, Cláudio Marcelo Bittencourt das
; Stefanini, Edson
; Manenti, Euler Roberto Fernandes
; Lima, Felipe Gallego
; Monteiro Júnior, Francisco das Chagas
; Correa Filho, Harry
; Pena, Henrique Patrus Mundim
; Pinto, Ibraim Masciarelli Francisco
; Falcão, João Luiz de Alencar Araripe
; Sena, Joberto Pinheiro
; Peixoto, José Maria
; Souza, Juliana Ascenção de
; Silva, Leonardo Sara da
; Maia, Lilia Nigro
; Ohe, Louis Nakayama
; Baracioli, Luciano Moreira
; Dallan, Luís Alberto de Oliveira
; Dallan, Luis Augusto Palma
; Mattos, Luiz Alberto Piva e
; Bodanese, Luiz Carlos
; Ritt, Luiz Eduardo Fonteles
; Canesin, Manoel Fernandes
; Rivas, Marcelo Bueno da Silva
; Franken, Marcelo
; Magalhães, Marcos José Gomes
; Oliveira Júnior, Múcio Tavares de
; Filgueiras Filho, Nivaldo Menezes
; Dutra, Oscar Pereira
; Coelho, Otávio Rizzi
; Leães, Paulo Ernesto
; Rossi, Paulo Roberto Ferreira
; Soares, Paulo Rogério
; Lemos Neto, Pedro Alves
; Farsky, Pedro Silvio
; Cavalcanti, Rafael Rebêlo C.
; Alves, Renato Jorge
; Kalil, Renato Abdala Karam
; Esporcatte, Roberto
; Marino, Roberto Luiz
; Giraldez, Roberto Rocha Corrêa Veiga
; Meneghelo, Romeu Sérgio
; Lima, Ronaldo de Souza Leão
; Ramos, Rui Fernando
; Falcão, Sandra Nivea dos Reis Saraiva
; Dalçóquio, Talia Falcão
; Lemke, Viviana de Mello Guzzo
; Chalela, William Azem
; Mathias Júnior, Wilson
.
https://doi.org/10.36660/abc.20210180
3052 downloads
9.
DROGAS IMUNOSSUPRESSORAS AFETAM OS NÚCLEOS HIPOTALÂMICOS ENVOLVIDOS NA INGESTÃO ALIMENTAR ? ESTUDO EXPERIMENTAL
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
SCHUH, Rodrigo
; VERONEZ, Djanira Aparecida da Luz
; RAMOS, Eduardo José Brommelstroet
; CUNHA, Flávia Dorieux Wastner
; PEREIRA, Mattheus Lopes
; ARANHA, Jeferson de Jesus
; ARANHA, Marcelo Alves
; MATIAS, Jorge Eduardo Fouto
.
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
- Journal Metrics
RESUMO - RACIONAL: Drogas imunossupressoras são indispensáveis para pacientes pós-transplante, diminuindo, significativamente, os riscos de rejeição inerentes a este tipo de procedimento. No entanto, seus efeitos colaterais sobre os núcleos hipotalâmicos envolvidos na regulação da ingestão de alimentos e o efeito no excessivo ganho de peso e suas comorbidades associadas são desconhecidos. OBJETIVO: Analisar a ocorrência de alterações morfológicas dos núcleos paraventricular, área hipotalâmica lateral, dorsomedial, ventromedial e arqueado em ratos Wistar submetidos ao tratamento imunossupressor com Tacrolimus (TAC) ou Micofenolato Mofetil (MMF). MÉTODOS: Foram utilizados Ratos Wistar machos adultos distribuídos, randomicamente, em quatro grupos de acordo com o tratamento oral utilizado por 14 semanas: Controle; Sham (Placebo); Tacrolimus (TAC 1mg/kg peso) e Micofenolato Mofetil (MMF 30mg/kg peso). Ao final do tratamento, os animais foram eutanasiados e seus encéfalos fixados para o processamento histológico. Posteriormente, as lâminas foram fotodocumentadas para o desenvolvimento da análise estereológica dos corpos celulares dos neurônios dos núcleos hipotalâmicos, tendo como parâmetros a densidade neuronal e no número de neurônios. RESULTADOS: Todos os grupos estudados mostraram curva de ganho de peso ponderal durante todo o período de experimento. Não houve diferença significativa na densidade neuronal e no número de neurônios hipotalâmicos dos núcleos hipotalâmicos entre os grupos estudados. Não foram detectadas alterações morfológicas dos corpos celulares dos neurônios hipotalâmicos capazes de serem imputadas ao uso dos imunossupressores envolvidos no estudo. CONCLUSÃO: O tratamento dos animais experimentais com os imunossupressores não evidenciou alterações no número e densidade dos corpos celulares dos neurônios dos núcleos hipotalâmicos estudados.
ABSTRACT - BACKGROUND: Immunosuppressive drugs are essential for reducing the rejection risk in post-transplant patients, which is commonly associated with this procedure. However, side effects of those drugs on the hypothalamic nuclei involved in the food intake regulation, excessive weight gain, and also associated comorbidities are still unknown. PURPOSE: The purpose of this study was to analyze possible changes in the neuronal morphology and cell density in the paraventricular nuclei, lateral hypothalamic area, dorsomedial nuclei, and ventromedial and arcuate nuclei in Wistar rats submitted to immunosuppressive treatment with tacrolimus (TAC) or mycophenolate mofetil (MMF). METHODS: Adult male Wistar rats were randomly assigned to the following groups according to the oral treatment administered for 14 weeks: control, sham (placebo), TAC (1 mg/kg of weight), and MMF (30 mg/kg of weight). After treatment, the animals were sacrificed and their brains fixed for later histological staining. Subsequently, the slides were photodocumented for stereological analysis of the hypothalamic nuclei. RESULTS: All experimental groups showed a weight gain throughout the study. There was no significant difference in neuronal density/number of cells in the hypothalamic nuclei between groups. Morphological changes were not detected in the hypothalamic neurons. CONCLUSION: Treatments with immunosuppressants could not modify the morphological and cell density aspects of the hypothalamic nuclei during this supplementation period.
10.
COVID-19: The question of genetic diversity and therapeutic intervention approaches
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Figueiredo, David Livingstone Alves
; Ximenez, João Paulo Bianchi
; Seiva, Fábio Rodrigues Ferreira
; Panis, Carolina
; Bezerra, Rafael dos Santos
; Ferrasa, Adriano
; Cecchini, Alessandra Lourenço
; Medeiros, Alexandra Ivo de
; Almeida, Ana Marisa Fusco
; Ramão, Anelisa
; Boldt, Angelica Beate Winter
; Moya, Carla Fredrichsen
; Chin, Chung Man
; Paula, Daniel de
; Rech, Daniel
; Gradia, Daniela Fiori
; Malheiros, Danielle
; Venturini, Danielle
; Tavares, Eliandro Reis
; Carraro, Emerson
; Ribeiro, Enilze Maria de Souza Fonseca
; Pereira, Evani Marques
; Tuon, Felipe Francisco
; Follador, Franciele Aní Caovilla
; Fernandes, Glaura Scantamburlo Alves
; Volpato, Hélito
; Cólus, Ilce Mara de Syllos
; Oliveira, Jaqueline Carvalho de
; Rodrigues, Jean Henrique da Silva
; Santos, Jean Leandro dos
; Visentainer, Jeane Eliete Laguila
; Brandi, Juliana Cristina
; Serpeloni, Juliana Mara
; Bonini, Juliana Sartori
; Oliveira, Karen Brajão de
; Fiorentin, Karine
; Lucio, Léia Carolina
; Faccin-Galhardi, Ligia Carla
; Ferreto, Lirane Elize Defante
; Lioni, Lucy Megumi Yamauchi
; Consolaro, Marcia Edilaine Lopes
; Vicari, Marcelo Ricardo
; Arbex, Marcos Abdo
; Pileggi, Marcos
; Watanabe, Maria Angelica Ehara
; Costa, Maria Antônia Ramos
; Giannini, Maria José S. Mendes
; Amarante, Marla Karine
; Khalil, Najeh Maissar
; Lima Neto, Quirino Alves de
; Herai, Roberto H.
; Guembarovski, Roberta Losi
; Shinsato, Rogério N.
; Mainardes, Rubiana Mara
; Giuliatti, Silvana
; Yamada-Ogatta, Sueli Fumie
; Gerber, Viviane Knuppel de Quadros
; Pavanelli, Wander Rogério
; Silva, Weber Claudio da
; Petzl-Erler, Maria Luiza
; Valente, Valeria
; Soares, Christiane Pienna
; Cavalli, Luciane Regina
; Silva Jr, Wilson Araujo
.
Abstract Coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus type 2 (SARS-CoV-2), is the largest pandemic in modern history with very high infection rates and considerable mortality. The disease, which emerged in China’s Wuhan province, had its first reported case on December 29, 2019, and spread rapidly worldwide. On March 11, 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a pandemic and global health emergency. Since the outbreak, efforts to develop COVID-19 vaccines, engineer new drugs, and evaluate existing ones for drug repurposing have been intensively undertaken to find ways to control this pandemic. COVID-19 therapeutic strategies aim to impair molecular pathways involved in the virus entrance and replication or interfere in the patients’ overreaction and immunopathology. Moreover, nanotechnology could be an approach to boost the activity of new drugs. Several COVID-19 vaccine candidates have received emergency-use or full authorization in one or more countries, and others are being developed and tested. This review assesses the different strategies currently proposed to control COVID-19 and the issues or limitations imposed on some approaches by the human and viral genetic variability.
11.
Epidemiologia e desfecho dos pacientes de alto risco cirúrgico admitidos em unidades de terapia intensiva no Brasil
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Silva Júnior, João Manoel
; Chaves, Renato Carneiro de Freitas
; Corrêa, Thiago Domingos
; Assunção, Murillo Santucci Cesar de
; Katayama, Henrique Tadashi
; Bosso, Fabio Eduardo
; Amendola, Cristina Prata
; Serpa Neto, Ary
; Malbouisson, Luiz Marcelo Sá
; Oliveira, Neymar Elias de
; Veiga, Viviane Cordeiro
; Rojas, Salomón Soriano Ordinola
; Postalli, Natalia Fioravante
; Alvarisa, Thais Kawagoe
; Lucena, Bruno Melo Nobrega de
; Oliveira, Raphael Augusto Gomes de
; Sanches, Luciana Coelho
; Silva, Ulysses Vasconcellos de Andrade e
; Nassar Junior, Antonio Paulo
; Réa-Neto, Álvaro
; Amaral, Alexandre
; Teles, José Mário
; Freitas, Flávio Geraldo Rezende de
; Bafi, Antônio Tonete
; Pacheco, Eduardo Souza
; Ramos, Fernando José
; Vieira Júnior, José Mauro
; Pereira, Maria Augusta Santos Rahe
; Schwerz, Fábio Sartori
; Menezes, Giovanna Padoa de
; Magalhães, Danielle Dourado
; Castro, Cristine Pilati Pileggi
; Henrich, Sabrina Frighetto
; Toledo, Diogo Oliveira
; Parra, Bruna Fernanda Camargo Silva
; Dias, Fernando Suparregui
; Zerman, Luiza
; Formolo, Fernanda
; Nobrega, Marciano de Sousa
; Piras, Claudio
; Piras, Stéphanie de Barros
; Conti, Rodrigo
; Bittencourt, Paulo Lisboa
; D’Oliveira, Ricardo Azevedo Cruz
; Estrela, André Ricardo de Oliveira
; Oliveira, Mirella Cristine de
; Reese, Fernanda Baeumle
; Motta Júnior, Jarbas da Silva
; Câmara, Bruna Martins Dzivielevski da
; David-João, Paula Geraldes
; Tannous, Luana Alves
; Chaiben, Viviane Bernardes de Oliveira
; Miranda, Lorena Macedo Araújo
; Brasil, José Arthur dos Santos
; Deucher, Rafael Alexandre de Oliveira
; Ferreira, Marcos Henrique Borges
; Vilela, Denner Luiz
; Almeida, Guilherme Cincinato de
; Nedel, Wagner Luis
; Passos, Matheus Golenia dos
; Marin, Luiz Gustavo
; Oliveira Filho, Wilson de
; Coutinho, Raoni Machado
; Oliveira, Michele Cristina Lima de
; Friedman, Gilberto
; Meregalli, André
; Höher, Jorge Amilton
; Soares, Afonso José Celente
; Lobo, Suzana Margareth Ajeje
.
RESUMO Objetivo: Definir o perfil epidemiológico e os principais determinantes de morbimortalidade dos pacientes cirúrgicos não cardíacos de alto risco no Brasil. Métodos: Estudo prospectivo, observacional e multicêntrico. Todos os pacientes cirúrgicos não cardíacos admitidos nas unidades de terapia intensiva, ou seja, considerados de alto risco, no período de 1 mês, foram avaliados e acompanhados diariamente por, no máximo, 7 dias na unidade de terapia intensiva, para determinação de complicações. As taxas de mortalidade em 28 dias de pós-operatório, na unidade de terapia intensiva e hospitalar foram avaliadas. Resultados: Participaram 29 unidades de terapia intensiva onde foram realizadas cirurgias em 25.500 pacientes, dos quais 904 (3,5%) de alto risco (intervalo de confiança de 95% - IC95% 3,3% - 3,8%), tendo sido incluídos no estudo. Dos pacientes envolvidos, 48,3% eram de unidades de terapia intensiva privadas e 51,7% de públicas. O tempo de internação na unidade de terapia intensiva foi de 2,0 (1,0 - 4,0) dias e hospitalar de 9,5 (5,4 - 18,6) dias. As taxas de complicações foram 29,9% (IC95% 26,4 - 33,7) e mortalidade em 28 dias pós-cirurgia 9,6% (IC95% 7,4 - 12,1). Os fatores independentes de risco para complicações foram Simplified Acute Physiology Score 3 (SAPS 3; razão de chance − RC = 1,02; IC95% 1,01 - 1,03) e Sequential Organ Failure Assessment Score (SOFA) da admissão na unidade de terapia intensiva (RC =1,17; IC95% 1,09 - 1,25), tempo de cirurgia (RC = 1,001; IC95% 1,000 - 1,002) e cirurgias de emergências (RC = 1,93; IC95% 1,10 - 3,38). Em adição, foram associados com mortalidade em 28 dias idade (RC = 1,032; IC95% 1,011 - 1,052) SAPS 3 (RC = 1,041; IC95% 1,107 - 1,279), SOFA (RC = 1,175; IC95% 1,069 - 1,292) e cirurgias emergenciais (RC = 2,509; IC95% 1,040 - 6,051). Conclusão: Pacientes com escores prognósticos mais elevados, idosos, tempo cirúrgico e cirurgias emergenciais estiveram fortemente associados a maior mortalidade em 28 dias e mais complicações durante permanência em unidade de terapia intensiva.
ABSTRACT Objective: To define the epidemiological profile and the main determinants of morbidity and mortality in noncardiac high surgical risk patients in Brazil. Methods: This was a prospective, observational and multicenter study. All noncardiac surgical patients admitted to intensive care units, i.e., those considered high risk, within a 1-month period were evaluated and monitored daily for a maximum of 7 days in the intensive care unit to determine complications. The 28-day postoperative, intensive care unit and hospital mortality rates were evaluated. Results: Twenty-nine intensive care units participated in the study. Surgeries were performed in 25,500 patients, of whom 904 (3.5%) were high-risk (95% confidence interval - 95%CI 3.3% - 3.8%) and were included in the study. Of the participating patients, 48.3% were from private intensive care units, and 51.7% were from public intensive care units. The length of stay in the intensive care unit was 2.0 (1.0 - 4.0) days, and the length of hospital stay was 9.5 (5.4 - 18.6) days. The complication rate was 29.9% (95%CI 26.4 - 33.7), and the 28-day postoperative mortality rate was 9.6% (95%CI 7.4 - 12.1). The independent risk factors for complications were the Simplified Acute Physiology Score 3 (SAPS 3; odds ratio - OR = 1.02; 95%CI 1.01 - 1.03) and Sequential Organ Failure Assessment Score (SOFA) on admission to the intensive care unit (OR = 1.17; 95%CI 1.09 - 1.25), surgical time (OR = 1.001, 95%CI 1.000 - 1.002) and emergency surgeries (OR = 1.93, 95%CI, 1.10 - 3.38). In addition, there were associations with 28-day mortality (OR = 1.032; 95%CI 1.011 - 1.052), SAPS 3 (OR = 1.041; 95%CI 1.107 - 1.279), SOFA (OR = 1.175, 95%CI 1.069 - 1.292) and emergency surgeries (OR = 2.509; 95%CI 1.040 - 6.051). Conclusion: Higher prognostic scores, elderly patients, longer surgical times and emergency surgeries were strongly associated with higher 28-day mortality and more complications during the intensive care unit stay.
https://doi.org/10.5935/0103-507x.20200005
1048 downloads
12.
Brazilian Thoracic Society recommendations for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Fernandes, Caio Julio Cesar dos Santos
; Ota-Arakaki, Jaquelina Sonoe
; Campos, Frederico Thadeu Assis Figueiredo
; Correa, Ricardo de Amorim
; Gazzana, Marcelo Basso
; Jardim, Carlos Vianna Poyares
; Jatene, Fábio Biscegli
; Alves Junior, Jose Leonidas
; Ramos, Roberta Pulcheri
; Tannus, Daniela
; Teles, Carlos
; Terra Filho, Mario
; Waetge, Daniel
; Souza, Rogerio
.
RESUMO A hipertensão pulmonar tromboembólica crônica (HPTEC) é uma doença grave e debilitante, causada pela oclusão do leito arterial pulmonar por êmbolos hemáticos e por material fibroso induzido pela presença desses êmbolos. Essa oclusão eleva a resistência vascular e, por consequência, a pressão do território arterial pulmonar, caracterizando a presença de hipertensão pulmonar. Esse aumento da carga imposta ao ventrículo direito leva a progressiva insuficiência do mesmo e, finalmente, ao óbito. No entanto, ao contrário das outras formas de hipertensão pulmonar, a HPTEC possui uma particularidade muito significativa: a existência de tratamento potencialmente curativo através da tromboendarterectomia pulmonar. Dessa forma, o objetivo primordial do manejo deve ser a avaliação do potencial cirúrgico do paciente em um centro de referência em HPTEC. Entretanto, nem todos os pacientes podem ser submetidos à cirurgia. Para esses pacientes outras alternativas terapêuticas viáveis são a angioplastia de artérias pulmonares e o tratamento farmacológico. Nestas recomendações, discutir-se-ão as bases fisiopatológicas para o surgimento de HPTEC, a partir da embolia pulmonar aguda, bem como o quadro clínico apresentado pelo paciente, o algoritmo diagnóstico a ser seguido e as alternativas terapêuticas disponíveis.
ABSTRACT Chronic thromboembolic pulmonary hypertension (CTEPH) is a serious and debilitating disease caused by occlusion of the pulmonary arterial bed by hematic emboli and by the resulting fibrous material. Such occlusion increases vascular resistance and, consequently, the pressure in the region of the pulmonary artery, which is the definition of pulmonary hypertension. The increased load imposed on the right ventricle leads to its progressive dysfunction and, finally, to death. However, CTEPH has a highly significant feature that distinguishes it from other forms of pulmonary hypertension: the fact that it can be cured through treatment with pulmonary thromboendarterectomy. Therefore, the primary objective of the management of CTEPH should be the assessment of patient fitness for surgery at a referral center, given that not all patients are good candidates. For the patients who are not good candidates for pulmonary thromboendarterectomy, the viable therapeutic alternatives include pulmonary artery angioplasty and pharmacological treatment. In these recommendations, the pathophysiological bases for the onset of CTEPH, such as acute pulmonary embolism and the clinical condition of the patient, will be discussed, as will the diagnostic algorithm to be followed and the therapeutic alternatives currently available.
13.
Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Précoma, Dalton Bertolim
; Oliveira, Gláucia Maria Moraes de
; Simão, Antonio Felipe
; Dutra, Oscar Pereira
; Coelho, Otávio Rizzi
; Izar, Maria Cristina de Oliveira
; Póvoa, Rui Manuel dos Santos
; Giuliano, Isabela de Carlos Back
; Alencar Filho, Aristóteles Comte de
; Machado, Carlos Alberto
; Scherr, Carlos
; Fonseca, Francisco Antonio Helfenstein
; Santos Filho, Raul Dias dos
; Carvalho, Tales de
; Avezum Jr., Álvaro
; Esporcatte, Roberto
; Nascimento, Bruno Ramos
; Brasil, David de Pádua
; Soares, Gabriel Porto
; Villela, Paolo Blanco
; Ferreira, Roberto Muniz
; Martins, Wolney de Andrade
; Sposito, Andrei C.
; Halpern, Bruno
; Saraiva, José Francisco Kerr
; Carvalho, Luiz Sergio Fernandes
; Tambascia, Marcos Antônio
; Coelho-Filho, Otávio Rizzi
; Bertolami, Adriana
; Correa Filho, Harry
; Xavier, Hermes Toros
; Faria-Neto, José Rocha
; Bertolami, Marcelo Chiara
; Giraldez, Viviane Zorzanelli Rocha
; Brandão, Andrea Araújo
; Feitosa, Audes Diógenes de Magalhães
; Amodeo, Celso
; Souza, Dilma do Socorro Moraes de
; Barbosa, Eduardo Costa Duarte
; Malachias, Marcus Vinícius Bolívar
; Souza, Weimar Kunz Sebba Barroso de
; Costa, Fernando Augusto Alves da
; Rivera, Ivan Romero
; Pellanda, Lucia Campos
; Silva, Maria Alayde Mendonça da
; Achutti, Aloyzio Cechella
; Langowiski, André Ribeiro
; Lantieri, Carla Janice Baister
; Scholz, Jaqueline Ribeiro
; Ismael, Silvia Maria Cury
; Ayoub, José Carlos Aidar
; Scala, Luiz César Nazário
; Neves, Mario Fritsch
; Jardim, Paulo Cesar Brandão Veiga
; Fuchs, Sandra Cristina Pereira Costa
; Jardim, Thiago de Souza Veiga
; Moriguchi, Emilio Hideyuki
; Schneider, Jamil Cherem
; Assad, Marcelo Heitor Vieira
; Kaiser, Sergio Emanuel
; Lottenberg, Ana Maria
; Magnoni, Carlos Daniel
; Miname, Marcio Hiroshi
; Lara, Roberta Soares
; Herdy, Artur Haddad
; Araújo, Cláudio Gil Soares de
; Milani, Mauricio
; Silva, Miguel Morita Fernandes da
; Stein, Ricardo
; Lucchese, Fernando Antonio
; Nobre, Fernando
; Griz, Hermilo Borba
; Magalhães, Lucélia Batista Neves Cunha
; Borba, Mario Henrique Elesbão de
; Pontes, Mauro Ricardo Nunes
; Mourilhe-Rocha, Ricardo
.
https://doi.org/10.5935/abc.20190204
40841 downloads
14.
The role of kinship in knowledge about medicinal plants: evidence for context-dependent model-based biases in cultural transmission?
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Brito, Camilla de Carvalho de
; Ferreira-Júnior, Washington Soares
; Albuquerque, Ulysses Paulino
; Ramos, Marcelo Alves
; Silva, Taline Cristina da
; Costa-Neto, Eraldo Medeiros
; Medeiros, Patrícia Muniz de
.
ABSTRACT The similarity in traditional knowledge of medicinal plants was evaluated to draw inferences about the most important models for local knowledge transmission. The following questions were addressed: (1) Do related individuals possess greater similarity in knowledge of medicinal plants than unrelated individuals? (2) Do related individuals of the same generation possess greater similarity in knowledge than do related individuals of different generations? Semi-structured interviews were conducted on the medicinal plants known by the residents of a rural community in western Bahia. Mann-Whitney tests were used to compare Jaccard similarity values between related and unrelated individuals and between relatives of the same generation and relatives of different generations. Related individuals were found to have more similar knowledge than unrelated individuals, and relatives of the same generation were found to have more similar knowledge than relatives of different generations. These findings suggest that there are factors that favor cultural transmission between relatives of the same generation other than just vertical transmission.
https://doi.org/10.1590/0102-33062018abb0340
781 downloads
15.
The use of firewood in protected forests: collection practices and analysis of legal restrictions to extractivism
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Nascimento, Luciana Gomes de Sousa
; Ramos, Marcelo Alves
; Albuquerque, Ulysses Paulino
; Araújo, Elcida de Lima
.
ABSTRACT Restrictions to the collection of timber resources in protected areas have been scarcely studied. The aim of this study was to describe the practices of firewood collection in a protected forest and the perceptions of collectors, particularly with regard to their adjustment to the rules of the local management plan. The study involved 102 participants of a rural community adjacent to the Araripe National Forest and employed semi-structured interviews, free-listing and in-situ survey techniques for ethnobiological data collection. The volume of wood stored was measured and monitored using a modification of the weight survey technique. The residents used 69 plant species for firewood Most of the informants self-reported disagreement with the rules of the management plan, yet they tended to comply. Most interviewees felt that the rules of the management plan needed to be changed, especially those related to the day when firewood can be collected, fees charged and means of transportation. Management plans certainly represent a relevant strategy for the conservation of biodiversity, but they need continuous evaluation and adjustment to meet the needs of local human populations.
https://doi.org/10.1590/0102-33062019abb0050
1321 downloads
Showing
itens per page
Page
of 3
Next
Statistics of
Send result
Sem resultados
No documents were found for your search
Glossary and search help
You can enrich your search in a very simple way. Use the search indexes combined with the connectors (AND or OR) and specify more your search.
For example, if you want to search for articles about
cases of dengue in Brasil in 2015, use:ti:dengue and publication_year:2015 and aff_country:Brasil
See below the complete list of search indexes that can be used:
Index code | Element |
---|---|
ti | article title |
au | author |
kw | article keywords |
subject | subject (title words, abstract and keywords) |
ab | abstract |
ta | journal short title (e.g. Cad. Saúde Pública) |
journal_title | journal full title (e.g. Cadernos de Saúde Pública) |
la | publication language code (e.g. pt - Portuguese, es - Spanish) |
type | document type |
pid | publication identifier |
publication_year | publication year of publication |
sponsor | sponsor |
aff_country | country code of the author's affiliation |
aff_institution | author affiliation institution |
volume | article volume |
issue | article issue |
elocation | elocation |
doi | DOI number |
issn | journal ISSN |
in | SciELO colection code (e.g. scl - Brasil, col - Colômbia) |
use_license | article usage license code |